RNS Number : 4280Y
Uniphar PLC
12 May 2021
AGM Results
Dublin, London | 12 May 2021
Uniphar plc is pleased to announce that at the Annual General Meeting held at 11.00 a.m. today, 12 May 2021, each of the resolutions set out in the Notice of Annual General Meeting circulated to shareholders and made available on the Company's website, www.uniphar.ie, were duly passed without amendment.
Details of votes cast are set out below:
RESOLUTION
TOTAL
FOR
%
AGAINST
%
ABSTAIN
1
Financial Statements and Reports
137,296,226
135,574,392
98.75
1,721,834
1.25
20,532
2
Final Dividend of €4.2m
137,296,226
137,293,095
100.00
3,131
0.00
20,532
3(a)
Re-elect Tim Dolphin
137,316,758
137,242,840
99.95
73,918
0.05
0
3(b)
Re-elect Padraic Dempsey
137,316,758
137,242,840
99.95
73,918
0.05
0
3(c)
Re-elect Paul Hogan
137,316,758
136,410,522
99.34
906,236
0.66
0
3(d)
Re-elect Maurice Pratt
137,316,758
137,219,247
99.93
97,511
0.07
0
4(a)
Elect Jeff Berkowitz
137,316,758
137,284,424
99.98
32,334
0.02
0
4(b)
Elect Jim Gaul
137,316,758
137,284,424
99.98
32,334
0.02
0
4(c)
Elect Liz Hoctor
137,316,758
137,293,695
99.98
23,063
0.02
0
5
Remuneration of Auditors
125,264,944
119,641,181
95.51
5,623,763
4.49
12,051,814
6
Allot relevant securities
137,296,100
135,196,092
98.47
2,100,008
1.53
20,658
7
Disapplication of pre-emption rights in specified circumstances
137,264,600
137,241,537
99.98
23,063
0.02
52,158
8
Disapplication of pre-emption rights in additional circumstances
137,264,600
137,185,914
99.94
78,686
0.06
52,158
9
Authorise market purchases of the Company's Ordinary Shares
137,304,627
137,281,564
99.98
23,063
0.02
12,131
10
Re-issuance of Treasury Shares
137,304,627
137,281,564
99.98
23,063
0.02
12,131
--- ENDS ---
For further details contact:
Uniphar
+353 (0) 1 428 7777
Brian O'Shaughnessy
Group Director of Corporate Development
investor.relations@Uniphar.ie
Davy
+353 (0) 1 679 6363
(Joint Broker, Nominated Adviser and Euronext Growth Adviser)
Fergal Meegan
Barry Murphy
Niall Gilchrist
RBC Capital Markets (Joint Broker)
+44 (0) 20 7653 4000
Jonathan Hardy
Jamil Miah Priyal Soni
Stifel Nicolaus Europe Limited (Joint Broker)
+44 (0) 20 7710 7600
Matt Blawat
Ben Maddison
Francis North
Q4 PR
+353 (0) 1 475 1444 or
(Public Relations Adviser to Uniphar)
+353 87 235 6461
Iarla Mongey
About Uniphar plc
Headquartered in Dublin, Ireland, Uniphar is an international diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,600, the Group is active in Ireland, the UK, the Benelux, the Nordics and the US.
The Company's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar represents a strong combination of scale, growth and profitability.
Commercial & Clinical
In Commercial & Clinical the Group provides sales, marketing & distribution solutions to multinational pharmaceutical and medical device manufacturers on an outsourced basis. Active in Ireland, the UK, Benelux, the Nordics and the US, the Group is growing with its clients to provide pan-European solutions. Uniphar has built a fully integrated multi-channel solution that is supported by our highly experienced and clinically trained teams leveraging our digital technology and insights which allows us to deliver consistently exceptional outcomes for our clients.
Product Access
n Product Access the Group is growing two distinct service offerings: 1) "On Demand Access", which are pharmacy led solutions for sourcing and supplying unlicensed medicines to meet the needs of both retail and hospital pharmacists; and 2) "Exclusive Access", which are manufacturer led solutions for controlling the release of speciality medicines for specifically approved patient populations in agreed markets. The Group currently delivers product access solutions on a global basis.
Supply Chain & Retail
Uniphar is an established market leader in Ireland with over a 50% market share in the wholesale/hospital market, supported by a network of c.330 owned, franchised and symbol group pharmacies. The business supports the diverse customer base through the provision of strong service levels coupled with innovative commercial initiatives. Supply Chain & Retail is an Irish only business for the Group, although the manufacturer relationships and infrastructure are utilised for the benefit of the growth divisions, Commercial & Clinical and Product Access.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGFLFLSEIIFLIL
